Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022 : recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults.: HP5-148/2022E-PDF

"On November 3, 2022, Health Canada authorized the use of the Moderna Spikevax 50 mcg BA.4/5 bivalent COVID-19 vaccine as a booster dose in individuals 18 years of age and older"--Overview, page 3.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.916714&sl=0

Publication information
Department/Agency Public Health Agency of Canada, issuing body.
Canada. National Advisory Committee on Immunization, issuing body.
Title Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022 : recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults.
Variant title Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults
Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Recommandations sur l'utilisation chez les adultes du vaccin de rappel à ARNm Spikevax bivalent BA.4/5 (50 mcg) de Moderna contre la COVID-19 : résumé des mises à jour du Comité consultatif national de l'immunisation (CCNI) du 3 novembre 2022.
Cover title.
"Pub.: 220546."
Publishing information Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, 2022.
©2022
Description 1 online resource (3 pages)
ISBN 9780660460291
Catalogue number
  • HP5-148/2022E-PDF
Departmental catalogue number 220546
Subject terms COVID-19 (Disease) -- Vaccination -- Canada.
COVID-19 (Disease) -- Vaccination -- Government policy -- Canada.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Date modified: